GlassScriptPhysician profile
Kyle J Kelschenbach
NPI 1669009676
$1,509.43
in general payments reported to CMS, 2019-2025
15 companies · $739 in 2025
The $739 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.67 · 2024: $751 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $435.71 | 2024-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $247.76 | 2024-2025 | Lifevest |
| Bridgebio Pharma, INC. | $165.72 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $146.36 | 2025 | Lokelma, Farxiga |
| Medtronic, INC. | $127.57 | 2025 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.08 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $56.01 | 2023-2024 | Ingevity+, Watchman Flx |
| Pfizer INC. | $51.25 | 2024-2025 | |
| Lantheus Medical Imaging, INC. | $37.26 | 2024 | |
| Medicomp INC | $32.80 | 2025 | Telepatch Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $28.69 | 2024 | Camzyos |
| Amgen INC. | $28.59 | 2025 | Repatha |
| Terumo Medical Corporation | $23.29 | 2025 | Progreat, Angio-Seal, Metacross Otw |
| Janssen Pharmaceuticals, INC | $19.24 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $19.10 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kelschenbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.